ASX slips back after hitting new high ahead of Fed decision. Iron ore prices expected to drop and Harvey Norman faces class ...

Paradigm Biopharmaceuticals says the FDA has endorsed key elements of its proposed phase III knee osteoarthritis trial.

Iron ore is flirting with a move below US$90/t, as concerns around China's demand for our top export continue to play out.

Mithril Silver and Gold survey more than doubles the number of known historical mines and workings at Copalquin Discovery ...

Good morning everyone, and welcome to Wednesday, September 18, 2024 – an important date in the history of news journalism.

Sun Silver (ASX:SS1) welcomes Nokomis Capital to the register and gets on rails for growth at Maverick Springs.

Blinklab expects rapid US approval for its phone-based autism test that can detect the condition within minutes.

Toubani Resources (ASX:TRE) adds serious mining muscle with the appointment of former Barrick and Gold Fields project ...

Rock chip sampling has delineated outcropping gold-silver-lead-zinc mineralisation outside of a resource for Argent Minerals ...

The Fed's expected rate cuts could spark rallies in small cap stocks, real estate, tech, silver and luxury sectors.

ASX peaks before closing near record on Fed rate cut hopes. Xero up on Syft buy, Microsoft announces US $60 billion buyback ...

Australia has a reputation as an attractive clinical trials destination generating $1.6bn for the economy in 2022, according ...